Thread Expands Collaboration with Datavant
Thread has announced the launch of a tokenization feature on its research platform that connects clinical trial and real-world data. This advancement, which expands Thread's collaboration with Datavant, leverages Datavant's connectivity tools that enable clients to tokenize, match, and link patient records across de-identified datasets while preserving patient privacy in compliance with regulations.
By engaging these tools to connect clinical trial data with real-world data, biopharmaceutical companies can unlock their studies' full potential by generating a longitudinal view of the patient journey. This solution supports advancing research data access to provide a deeper understanding of patient outcomes.
"Thread's enhanced tokenization feature, backed by Datavant's leading de-identification technology, is a powerful shift in the way real-world data can be integrated into clinical trials. Our customers can now gain and integrate their clinical and real-world data in a few clicks to support their goal of generating additional evidence," said Thread Co-Founder and CEO John Reites in a press release.
"Linking clinical trial data with real-world data can yield enormous benefits for both life sciences researchers and patients, by generating better evidence on treatment safety and efficacy while reducing the burden on trial participants," said Tal Rosenberg, president and general manager, life sciences, ecosystem & public sector at Datavant in a press release. "We're thrilled to enhance our use case by embedding Datavant's technology onto Thread's no-code platform and offering the power of connected clinical trials to a broader customer base."
Reference
THREAD EXPANDS DATAVANT PARTNERSHIP TO LAUNCH FULLY CONFIGURABLE SOLUTION FOR REAL-WORLD DATA LINKAGE. (2023, October 3). Cision PR Newswire.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Looking Forward in the Feasibility/AI Space
May 6th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Rohit Nambisan, CEO & founder of Lokavant looks into the future of feasibility studies, the integration of AI, and how they are driving more personalized approaches.
